These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 16584205)
1. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3. Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205 [TBL] [Abstract][Full Text] [Related]
2. Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity. van der Woning SP; Venselaar H; van Rotterdam W; Jacobs-Oomen S; van Leeuwen JE; van Zoelen EJ Growth Factors; 2009 Jun; 27(3):163-72. PubMed ID: 19384683 [TBL] [Abstract][Full Text] [Related]
3. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction. Borer JG; Park JM; Atala A; Nguyen HT; Adam RM; Retik AB; Freeman MR Lab Invest; 1999 Nov; 79(11):1335-45. PubMed ID: 10576204 [TBL] [Abstract][Full Text] [Related]
4. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253 [TBL] [Abstract][Full Text] [Related]
5. Bivalence of EGF-like ligands drives the ErbB signaling network. Tzahar E; Pinkas-Kramarski R; Moyer JD; Klapper LN; Alroy I; Levkowitz G; Shelly M; Henis S; Eisenstein M; Ratzkin BJ; Sela M; Andrews GC; Yarden Y EMBO J; 1997 Aug; 16(16):4938-50. PubMed ID: 9305636 [TBL] [Abstract][Full Text] [Related]
6. Ligand depletion negatively controls the mitogenic activity of epidermal growth factor. van de Poll ML; van Rotterdam W; Gadellaa MM; Jacobs-Oomen S; van Zoelen EJ Exp Cell Res; 2005 Apr; 304(2):630-41. PubMed ID: 15748906 [TBL] [Abstract][Full Text] [Related]
7. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors. Zhan L; Xiang B; Muthuswamy SK Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444 [TBL] [Abstract][Full Text] [Related]
8. The extracellular domains of ErbB3 retain high ligand binding affinity at endosome pH and in the locked conformation. Kani K; Park E; Landgraf R Biochemistry; 2005 Dec; 44(48):15842-57. PubMed ID: 16313187 [TBL] [Abstract][Full Text] [Related]
9. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Piepkorn M; Predd H; Underwood R; Cook P Arch Dermatol Res; 2003 Jul; 295(3):93-101. PubMed ID: 12768307 [TBL] [Abstract][Full Text] [Related]
10. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands. van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651 [TBL] [Abstract][Full Text] [Related]
11. A betacellulin mutant promotes differentiation of pancreatic acinar AR42J cells into insulin-producing cells with low affinity of binding to ErbB1. Nagaoka T; Fukuda T; Hashizume T; Nishiyama T; Tada H; Yamada H; Salomon DS; Yamada S; Kojima I; Seno M J Mol Biol; 2008 Jun; 380(1):83-94. PubMed ID: 18508082 [TBL] [Abstract][Full Text] [Related]
12. Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor. Azios NG; Romero FJ; Denton MC; Doherty JK; Clinton GM Oncogene; 2001 Aug; 20(37):5199-209. PubMed ID: 11526509 [TBL] [Abstract][Full Text] [Related]
13. Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart. Campreciós G; Lorita J; Pardina E; Peinado-Onsurbe J; Soley M; Ramírez I J Cell Physiol; 2011 Feb; 226(2):450-5. PubMed ID: 20672328 [TBL] [Abstract][Full Text] [Related]
14. The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion. Yokoe S; Takahashi M; Asahi M; Lee SH; Li W; Osumi D; Miyoshi E; Taniguchi N Cancer Res; 2007 Mar; 67(5):1935-42. PubMed ID: 17332320 [TBL] [Abstract][Full Text] [Related]
15. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Sanderson MP; Dempsey PJ; Dunbar AJ Growth Factors; 2006 Jun; 24(2):121-36. PubMed ID: 16801132 [TBL] [Abstract][Full Text] [Related]
16. Differentiation of a mouse submandibular gland-derived cell line (SCA) grown on matrigel. Barka T; Gresik ES; Miyazaki Y Exp Cell Res; 2005 Aug; 308(2):394-406. PubMed ID: 15922327 [TBL] [Abstract][Full Text] [Related]
17. Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2. Xu X; Kelleher KF; Liao J; Creek KE; Pirisi L Oncogene; 2000 Jun; 19(28):3172-81. PubMed ID: 10918572 [TBL] [Abstract][Full Text] [Related]
18. Structure of the extracellular region of HER3 reveals an interdomain tether. Cho HS; Leahy DJ Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198 [TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2. Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749 [TBL] [Abstract][Full Text] [Related]
20. Quantification of ErbB3 receptor density on human breast cancer cells, using a stable radio-labeled mutant of NRG1beta. van der Woning SP; van Zoelen EJ Biochem Biophys Res Commun; 2009 Jan; 378(2):285-9. PubMed ID: 19026613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]